Infectious Disease Control
Kintor Pharma Announces Brazil's ANVISA Approves Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients
SUZHOU, China, Sept. 26, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that onSeptember 22 the Brazilian Health Regulatory Agency (ANVISA) ...
2021-09-26 23:09
5846
Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases
- Pivotal Phase 3 trial achieved all primary endpoints, demonstrating non-inferiority to a leading U.S.-licensed quadrivalent influenza vaccine - NanoFlu™ vaccine candidate induced significantly enhanced cell-mediated immune responses - NanoFlu was well-tolerated with a comparable safety profile...
2021-09-24 08:47
4654
/C O R R E C T I O N -- pHOXBIO/
In the news release, pHOXBIO Announces Breakthrough Clinical Trial Results Concluding Prophylactic Nasal Spray Prevents Infection from SARS-CoV-2, issued Sept. 22, 2021 by pHOXBIO over PR Newswire, we are advised by the company that the hyperlinks have been revised. The complete, corrected releas...
2021-09-24 02:42
2162
Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine
* Novavax and Serum Institute of India file regulatory submission for World Health Organization Emergency Use Listing of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine GAITHERSBURG, Md., Sept. 23, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedic...
2021-09-23 21:59
6410
BioVaxys Prepares for Groundbreaking Study on reduced ACE2 binding capabilities of Hapten-modified SARS-CoV-2 proteins
- Potential for superior tolerability to mRNA and Adenovirus Vector vaccines - Production Agreement signed with Millipore-Sigma for SARS-CoV-2 Vaccine Supply VANCOUVER, BC, Sept. 23, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), a...
2021-09-23 15:00
5565
INOVIO Receives Regulatory Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800, in Mexico
News follows recent regulatory authorizations to proceed with the trial in Brazil and the Philippines INOVIO and partner Advaccine are collaborating on the global Phase 3 trial in regions underserved by COVID-19 vaccines; to focus onLatin America, Asia, and Africa PLYMOUTH MEETING, Pa., Sept. 2...
2021-09-22 20:00
5131
Clover's COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest
* Trial enrolled over 30,000 adult & elderly participants across 4 continents; 100% of SARS-CoV-2 strains observed in efficacy analysis were variants (Delta was predominant strain) * Primary and secondary efficacy endpoints were successfully met * 100% efficacy against severe COVID-19 & hosp...
2021-09-22 18:56
1695
Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug
SHELTON, Conn., Sept. 22, 2021 /PRNewswire/ -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reported today on the significant advantages gained by remdesivir encapsulation ...
2021-09-22 18:45
5073
The International Standard Proposed by Experts from BMC Medical in Terms of High-flow Respiratory Therapy Equipment Officially Released
BEIJING, Sept. 22, 2021 /PRNewswire/ -- The international standard for high-flow respiratory therapy equipment (standard number: ISO 80601-2-90:2021) proposed by BMC Medical standardization technical experts has been formally released recently on the official websites of the International Organiz...
2021-09-22 15:00
2912
FII Institute Launches Global Infectious Diseases Index
FII Institute launched a unique global index that uses groundbreaking technology to track infectious diseases and transform how the world reacts to future crises. The Global Infectious Diseases Index was developed by FII Institute in partnership with Accenture and Metabiota. Metabiota's risk so...
2021-09-21 23:19
3001
Novavax to Participate in Fireside Chat at Devex @ UNGA 76
GAITHERSBURG, Md., Sept. 21, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing and commercializing next-generation vaccines for serious infectious diseases, today announced thatJohn J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Busin...
2021-09-21 04:46
7065
P&G partners with Philippine Red Cross for COVID-19 Bakuna Buses in CALABARZON
MANILA, Philippines, Sept. 20, 2021 /PRNewswire/ -- Procter & Gamble (P&G)
Philippines continues stepping up as a force for good by supporting the
Philippine Red Cross (PRC) mission to assist in the government's national
COVID-19 vaccination program.
2021-09-20 15:09
1964
Experts Call on World Leaders to Commit to a Global Plan of Attack on COVID at Summit
More Than 60 Leading Organizations Across Civil Society, Academia, Philanthropy, Health, and Social Enterprise Define a 6-Point Plan to End the Global COVID-19 Crisis SEATTLE, Sept. 20, 2021 /PRNewswire/ -- This week, hosted by the United States , world leaders will gather virtually for theGlobal...
2021-09-20 12:00
2198
New Zealand's Cancer Organisations Warn Of COVID Pandemic-led Drop In Cancer Being Diagnosed And Treated
* Growing concern that people are reluctant to see their doctor about troubling symptoms during current uncertain period. This follows last year's lockdown which saw a decline in diagnosis of cancer across Aotearoa.[1] * Around 9,000 New Zealanders die of cancer every year.[2] * New campai...
2021-09-20 06:00
1807
SARS-CoV-2, Influenza A inactivated by zinc-embedded nylon fabric
A paper published in ACS Applied Materials Interfaces details effectiveness, describes protocol for future testing HOUSTON, Sept. 18, 2021 /PRNewswire/ -- An international team of scientists and engineers from theUniversity of Cambridge, the Icahn School of Medicine at Mount Sinai, ResInnova Lab...
2021-09-18 04:53
4077
COVID-19 Scoop: Epoch-Making GoldenBiotech's Oral COVID-19 New Drug Trial Got Green Light from the FDA to Extend Recruiting Severe COVID-19 Patients
TAIPEI, Sept.16, 2021 /PRNewswire/ -- Golden Biotechnology Corp.(TPEx:4132) ("GoldenBiotech", GBC), a leading Taiwanese biopharmaceutical company, announces that its oral investigational new drug Antroquinonol (HOCENA®) has made headway withCOVID-19 treatment development in more broaden clinical ...
2021-09-16 18:05
2056
Key milestone: DHL delivers 1 billion COVID-19 vaccine doses
* 1 billion vaccine doses shipped to more than 160 countries in the fight against COVID-19 sinceDecember 2020 * Smooth management and execution of different supply chain set-ups * Planning essential to identify and prevent future health emergencies SINGAPORE, Sept. 16, 2021 /PRNewswire/ -- C...
2021-09-16 16:00
15151
Sputnik V Demonstrates 97.2% Efficacy And High Safety Profile Against COVID During The Vaccination Campaign In Belarus
MOSCOW, Sept. 15, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the real world data of the Ministry of Health of theRepublic of Belarus on the Russian Sputnik V coronavirus vaccine confirming its high efficacy during the vaccination campai...
2021-09-15 16:00
1570
iGene Laboratory donates 25,000 SARS-CoV-2 PCR Kits to Indonesia
SINGAPORE, Sept. 15, 2021 /PRNewswire/ -- iGene Laboratory Pte. Ltd donates 25,000 SARS-CoV-2 PCR Kits toIndonesia to assist the government of the Republic ofIndonesia in managing the COVID-19 disease outbreak. The occasion was marked with a symbolic hand-over ceremony at the Republic of Indonesi...
2021-09-15 10:22
2408
Humanforce Releases Solution to Help Employers Manage COVID-19 Vaccination Policies
SYDNEY, Sept. 15, 2021 /PRNewswire/ -- As increasing vaccination rates become a primary path towards reopeningAustralia, local workers are indicating a preference to work in environments where their colleagues are vaccinated. To assist businesses in managing complex workplace vaccination issues,H...
2021-09-15 07:00
2055
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
6801
